Reducing greenhouse gas emissions is a major challenge. Inhalers have a significant impact on the environment due to their greenhouse gas emissions. However, inhalation therapy plays a fundamental and essential role in the treatment of patients with cystic fibrosis. They therefore represent a target group with high potential for the implementation of strategic measures to reduce the environmental impact of devices.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Disorders of the Gut-Brain Interaction
Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial
- Gepante for Migraines
Relief from pain, symptoms, and improved functional ability—both acute and preventive
- Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance
Potassium binders as enablers of RAASi optimization
- Asthma in Adults: Bronchodilation and Anti-Inflammatory Therapy
Remodeling can be counteracted through a proactive treatment strategy
- From symptom to diagnosis
Gynecomastia and Adipomastia
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management